Scientific Committee

Jonathan Noujaim

Clinical Trials, Sarcoma Research, Biobank Leadership, Translational Research, Patient Access

Dr. Noujaim leads several clinical studies as the principal investigator, focusing on enhancing clinical trial access and fostering sarcoma research throughout Quebec. He directs the Maisonneuve-Rosemont Sarcoma Biobank and plays a pivotal role in advancing the sarcoma translational research program as a clinical associate at the Centre de recherche de l’Hôpital Maisonneuve-Rosemont.

Learn More

Ramy Saleh

Phase I Drug Development, Clinical Research, Oncology Leadership and collaboration, Translational Oncology

Dr. Saleh specializes in Phase I drug development and has been instrumental in enrolling the first patient into the Calgary CART T-cell trial for advanced alveolar soft-part sarcoma (ASPS). He serves as the Medical Director of Oncology Clinical Trials at the Centre for Innovative Medicine (CIM) at the Research Institute of the MUHC (RI-MUHC).

Learn More

Livia Garzia

Pediatric and AYA sarcoma, functional genomics, epigenetics, model systems

Dr. Garzia's lab investigates the molecular basis of metastasis and therapy resistance in pediatric solid cancers such as sarcomas and brain cancers. The lab uses genomics on patient samples followed by in vivo functional genomics models, aiming to prevent or cure metastasis in these cancer types.

Learn More

Anthony Bozzo

Orthopedic Oncology, Sarcoma, Multimodal Neural Networks, Collaborative Multicenter AI studies, Federated Learning

Dr. Bozzo has developed a multimodal neural network model to predict survival and metastasis in sarcoma patients, integrating clinical variables and MRI images. His research aims to personalize treatment strategies for sarcoma patients using artificial intelligence.

Learn More

Natalia Gorelik

Musculoskeletal imaging, Oncologic surveillance, Outcome prediction, Comparative effectiveness, Clinical applications of artificial intelligence

Dr. Gorelik's research includes evaluating patterns of imaging utilization after resection of extremity soft tissue sarcoma and assessing potential disparities in care. Her work aims to optimize imaging strategies for sarcoma patients and improve clinical outcomes.

Learn More

Julien Montreuil

Musculoskeletal Oncology, Arthroplasty, 3D modeling, Custom implants

Dr. Montreuil's research focuses on the development and application of 3D printing technologies to create custom implants for patients undergoing sarcoma surgery. His work aims to improve surgical outcomes and quality of life for sarcoma patients.

Learn More

Sinziana Dumitra

Quality of Care, Access to Treatment, Digital Health, Sarcoma Management, Outcome Improvement

Dr. Dumitra's research focuses on improving access and quality of cancer care, with clinical interests in sarcoma, peritoneal surface malignancies, and melanoma. She has contributed to defining and assessing quality indicators of sarcoma care through a novel interoperable digital platform.

Learn More

James Tsui

Radiation Oncology, Clinical Trials, Artificial Intelligence, Deep Learning, Radiation Intensification

Dr. Tsui's research interests focus on the intersection of machine learning and medicine, aiming to bring artificial intelligence into oncology research and clinical practice. His projects include developing tools to predict hospital admissions for elderly cancer patients presenting to the emergency room.

Learn More

El Bachir Affar

Researcher: Cell signaling, mechanisms of cancer, biomarkers, sarcoma biobanking

Dr El Bachir Affar leads the Cell Signaling and Cancer Research Unit at the Maisonneuve-Rosemont Hospital Research Centre and is a professor at the Université de Montréal. His research focuses on cell signaling, epigenetic regulation, and the molecular basis of cancer and sarcoma. His team leverages genomics and proteomics to uncover new mechanisms and therapeutic targets, supporting the development of precision-medicine strategies.

Learn More